Astrazeneca Spain News Today : Breaking News, Live Updates & Top Stories | Vimarsana

SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company and a leader in data-driven medicine, today announced it has expanded an existing program in Spain to increase access to local testing for homologous recombination deficiency (HRD) throughout the country. The expansion of the program, supported by AstraZeneca Spain and its network throughout the country, will further SOPHiA GENETICS' commitment to global health equity by making this vital testing available to thousands more patients

United kingdomMarta morenoKevin puylaertInstagram astrazenecaFamily responsible companyCorporate affairsAstrazeneca spainMarket accessManaging directorRare diseasesTop employersFamily responsibleVitro diagnostic useLooking statementsCancer patientsOvarian cancer